SEC 13F Intelligence

Altium Capital Management LLC / VKTX

Altium Capital Management LLC’s Viking Therapeutics Inc Position

Does Altium Capital Management LLC own Viking Therapeutics Inc (VKTX)? Not currently — the last reported position was 146.0K shares worth $6M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q4 2024
Shares
146.0K
% of Portfolio
+1.67%
Quarters Held
4
position exited

Position History VKTX

Reported value by quarter
Q1 ’24: $7MQ1 ’24Q2 ’24: $6MQ2 ’24Q3 ’24: $8MQ3 ’24Q4 ’24: $6MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024146.0K$6M+1.67%
Q3 2024126.0K$8M+2.35%
Q2 2024122.0K$6M+2.64%
Q1 202485.0K$7M+2.76%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of VKTX.